Lithium-mediated protection against ethanol neurotoxicity

Frontiers in Neuroscience

Volumn 4, Issue JUN, 2010, Pages

  Luo, Jia ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alcohol; Apoptosis; Development; Fetal alcohol syndrome; Neurodegeneration; Neuroprotection

Indexed keywords

EID: 77958089576     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2010.00041     Document Type: Review

References (47)

1. Archibald, S. L., Fennema-Notestine, C., Gamst, A., Riley, E. P., Mattson, S. N., and Jernigan, T. L. (2001). Brain dysmorphology in individuals with severe prenatal alcohol exposure. Dev. Med. Child Neurol. 43, 148-154.
2. Bielecka, A. M., and Obuchowicz, E. (2008). Antiapoptotic action of lithium and valproate. Pharmacol. Rep. 60, 771-782.
3. Bookstein, F. L., Streissguth, A. P., Connor, P. D., and Sampson, P. D. (2006). Damage to the human cerebellum from prenatal alcohol exposure: the anatomy of a simple biometrical explanation. Anat. Rec. B New Anat. 289, 195-209.
4. Calderó, J., Brunet, N., Tarabal, O., Piedrafita, L., Hereu, M., Ayala, V., and Esquerda, J. E. (2010). Lithium prevents excitotoxic cell death of motoneurons in organotypic slice cultures of spinal cord. Neuroscience 165, 1353-1369.
5. Carter, J. J., Tong, M., Silbermann, E., Lahousse, S. A., Ding, F. F., Longato, L., Roper, N., Wands, J. R., and de la Monte, S. M. (2008). Ethanol impaired neuronal migration is associated with reduced aspartyl-asparaginyl-beta-hydroxylase expression. Acta Neuropathol. 116, 303-315.
6. Chakraborty, G., Saito, M., Mao, R. F., Wang, R., Vadasz, C., and Saito, M. (2008). Lithium blocks ethanol-induced modulation of protein kinases in the developing brain. Biochem. Biophys. Res. Commun. 367, 597-602.
7. Chen, G., Bower, K. A., Ma, C., Fang, S., Thiele, C. J., and Luo, J. (2004). Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death. FASEB J. 18, 1162-1164.
8. Chen, G., Bower, K. A., Xu, M., Ding, M., Shi, X., Ke, Z. J., and Luo, J. (2009). Cyanidin-3-glucoside reverses ethanol-induced inhibition of neurite outgrowth: role of glycogen synthase kinase 3 beta. Neurotox. Res. 15, 321-331.
9. Clarren, S. K., Alvord, E. J., Sumi, S. M., Streissguth, A. P., and Smith, D. W. (1978). Brain malformations related to prenatal exposure to ethanol. J. Pediatr. 92, 64-67.
10. Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., Mills, D., Brown, M. J., Haigh, D., Ward, R. W., Smith, D. G., Murray, K. J., Reith, A. D., and Holder, J. C. (2000). Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7, 793-803.
11. Danis, R. P., Newton, N., and Keith, L. (1981). Pregnancy and alcohol. Curr. Probl. Obstet. Gynecol. 4, 2-48.
12. de la Monte, S. M., and Wands, J. R. (2002). Chronic gestational exposure to ethanol impairs insulin-stimulated survival and mitochondrial function in cerebellar neurons. Cell. Mol. Life Sci. 59, 882-893.
13. Doble, B. W., and Woodgett, J. R. (2003). GSK-3: tricks of the trade for a multi-tasking kinase. J. Cell Sci. 116, 1175-1186.
14. Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., Modugno, N., Siciliano, G., Isidoro, C., Murri, L., Ruggieri, S., and Paparelli, A. (2008). Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A. 105, 2052-2057.
15. French, R. L., and Heberlein, U. (2009). Glycogen synthase kinase-3/Shaggy mediates ethanol-induced excitotoxic cell death of Drosophila olfactory neurons. Proc. Natl. Acad. Sci. U.S.A. 106, 20924-20929.
16. Gill, A., Kidd, J., Vieira, F., Thompson, K., and Perrin, S. (2009). No benefit from chronic lithium dosing in a sibling-matched, gender balanced, investigator-blinded trial using a standard mouse model of familial ALS. PLoS ONE 4, e6489. doi: 10.1371/journal.pone.0006489.
17. Gille, J. J., and Bannigan, J. G. (2006). Teratogenic and developmental effects of lithium. Curr. Pharm. Des. 12, 1531-1541.
18. Grimes, C. A., and Jope, R. S. (2001). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog. Neurobiol. 65, 391-426.
19. Harper, C. (2009). The neuropathology of alcohol-related brain damage. Alcohol Alcohol. 44, 136-140.
20. Ishii, T., Hashimoto, E., Ukai, W., Tateno, M., Yoshinaga, T., Saito, S., Sohma, H., and Saito, T. (2008). Lithium-induced suppression of transcription repressor NRSF/REST: effects on the dysfunction of neuronal differentiation by ethanol. Eur. J. Pharmacol. 593, 36-43.
21. Jope, R. S. (2003). Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441-443.
22. Liang, M. H., Wendland, J. R., and Chuang, D. M. (2008). Lithium inhibits Smad3/4 transactivation via increased CREB activity induced by enhanced PKA and AKT signaling. Mol. Cell. Neurosci. 37, 440-453.
23. Liu, Y., Chen, G., Ma, C., Bower, K. A., Xu, M., Fan, Z., Shi, X., Ke, Z. J., and Luo, J. (2009). Over-expression of GSK3 beta sensitizes neuronal cells to ethanol toxicity. J. Neurosci. Res. 87, 2793-2802.
24. Luo, J. (2009). GSK3beta in ethanol neurotoxicity. Mol. Neurobiol. 40, 108-121.
25. Machado-Vieira, R., Manji, H. K., and Zarate, C. A. Jr. (2009). The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis. Bipolar Disord. 11(Suppl. 2), 92-109.
26. Marmol, F. (2008). Lithium: bipolar disorder and neurodegenerative diseases, possible cellular mechanisms of the therapeutic effects of lithium. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1761-1771.
27. Martinez, A., Alonso, M., Castro, A., Pérez, C., and Moreno, F. J. (2002). First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J. Med. Chem. 45, 1292-1299.
28. May, P. A., and Gossage, J. P. (2001). Estimating the prevalence of fetal alcohol syndrome. Alcohol Res. Health 25, 159-167.
29. Nash, K., Sheard, E., Rovet, J., and Koren, G. (2008). Understanding fetal alcohol spectrum disorders (FASDs): toward identification of a behavioral phenotype. ScientificWorldJournal 8, 873-882.
30. Neznanova, O., Björk, K., Rimondini, R., Hansson, A. C., Hyytiä, P., Heilig, M., and Sommer, W. H. (2009). Acute ethanol challenge inhibits glycogen synthase kinase-3beta in the rat prefrontal cortex. Int. J. Neuropsychopharmacol. 12, 275-280.
31. Obernier, J. A., Bouldin, T. W., and Crews, F. T. (2002). Binge ethanol exposure in adult rats causes necrotic cell death. Alcohol. Clin. Exp. Res. 26, 547-557.
32. Olney, J. W., Ishimaru, M. J., Bittigau, P., and Ikonomidou, C. (2000). Ethanol-induced apoptotic neurodegeneration in the developing brain. Apoptosis 5, 515-521.
33. Pfefferbaum, A., Adalsteinsson, E., Bell, R. L., and Sullivan, E. V. (2007). Development and resolution of brain lesions caused by pyrithiamine-and dietary-induced thiamine deficiency and alcohol exposure in the alcohol-preferring rat: a longitudinal magnetic resonance imaging and spectroscopy study. Neuropsychopharmacology 32, 1159-1177.
34. Pies, R. (2002). Combining lithium and anticonvulsants in bipolar disorder: a review. Ann. Clin. Psychiatry 14, 223-232.
35. Pizzasegola, C., Caron, I., Daleno, C., Ronchi, A., Minoia, C., Carrì, M. T., and Bendotti, C. (2009). Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice. Amyotroph. Lateral Scler. 10, 221-228.
36. Riley, E. P., and McGeem, C. L. (2005). Fetal alcohol spectrum disorders: an overview with emphasis on changes in brain and behavior. Exp. Biol. Med. (Maywood) 230, 357-365.
37. Saito, M., Chakraborty, G., Mao, R. F., Paik, S. M., Vadasz, C., and Saito, M. (2010). Tau phosphorylation and cleavage in ethanol-induced neurodegeneration in the developing mouse brain. Neurochem. Res. 35, 651-659.
38. Sasaki, T., Han, F., Shioda, N., Moriguchi, S., Kasahara, J., Ishiguro, K., and Fukunaga, K. (2006). Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model. Brain Res. 1108, 98-106.
39. Sowell, E. R., Mattson, S. N., Kan, E., Thompson, P. M., Riley, E. P., and Toga, A. W. (2008). Abnormal cortical thickness and brain-behavior correlation patterns in individuals with heavy prenatal alcohol exposure. Cereb. Cortex 18, 136-144.
40. Stratton, K., Howe, C., and Battagila, F. (eds.) (1996). Fetal Alcohol Syndrome: Diagnosis, Epidemiology, Prevention, and Treatment. Washington DC: National Academy Press.
41. Swayze, V. W. 2nd, Johnson, V. P., Hanson, J. W., Piven, J., Sato, Y., Giedd, J. N., Mosnik, D., and Andreasen, N. C. (1997). Magnetic resonance imaging of brain anomalies in fetal alcohol syndrome. Pediatrics 99, 232-240.
42. Takadera, T., and Ohyashiki, T. (2004). Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons. Eur. J. Pharmacol. 499, 239-245.
43. Wada, A. (2009). Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3beta, beta-catenin, and neurotrophin cascades. J. Pharmacol. Sci. 110, 14-28.
44. Young, C., and Olney, J. W. (2006). Neuroapoptosis in the infant mouse brain triggered by a transient small increase in blood alcohol concentration. Neurobiol. Dis. 22, 548-554.
45. Young, C., Straiko, M. M., Johnson, S. A., Creeley, C., and Olney, J. W. (2008). Ethanol causes and lithium prevents neuroapoptosis and suppression of pERK in the infant mouse brain. Neurobiol. Dis. 31, 355-360.
46. Zhong, J., Yang, X., Yao, W., and Lee, W. (2006). Lithium protects ethanol-induced neuronal apoptosis. Biochem. Biophys. Res. Commun. 350, 905-910.
47. Zhou, K., Zhang, L., Xi, J., Tian, W., and Xu, Z. (2009). Ethanol prevents oxidant-induced mitochondrial permeability transition pore opening in cardiac cells. Alcohol Alcohol. 44, 20-24.